Clopidogrel-induced sweet syndrome: severe dermatological complication after percutaneous coronary intervention

Eur Heart J. 2021 Jul 8;42(26):2610. doi: 10.1093/eurheartj/ehaa656.
No abstract available

MeSH terms

  • Acute Coronary Syndrome*
  • Clopidogrel / adverse effects
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors / adverse effects
  • Prasugrel Hydrochloride
  • Sweet Syndrome* / chemically induced
  • Ticlopidine / adverse effects
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Prasugrel Hydrochloride
  • Ticlopidine